Houston TX 消化系统疾病临床试验
8项针对 消化系统疾病的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Baylor College of Medicine, Houston
- Intergrity Research, Houston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Oncology Consultants P.A., Houston
- Oncology Consultants P.A., Houston
- Texas Oncology - Gulf Coast, Houston
- 以及另外 7 项
Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
招募中
- Baylor College of Medicine / Texas Children's Hospital, Houston
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
招募中3 期
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 以及另外 1 项
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
招募中
- University of Texas Health Science Center at Houston, Houston
GpCRC Pediatric Gastroparesis Registry 2
招募中观察性研究
- Baylor College of Medicine/Texas Children's Hospital, Houston
其他城市的 消化系统疾病试验
- New York City, NY8 项研究
- Chicago, IL8 项研究
- Washington, DC6 项研究
- Durham, NC6 项研究
- Boston, MA6 项研究
- San Diego, CA6 项研究
- Rochester, MN5 项研究
- San Antonio, TX5 项研究
- St. Louis, MO5 项研究
- Cincinnati, OH5 项研究
- Sarasota, FL5 项研究
- Tyler, TX5 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）122 项研究
- 转移性癌症104 项研究
- 结直肠癌103 项研究
- 卵巢癌90 项研究
- 急性髓系白血病86 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌69 项研究
- 胰腺癌62 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。